Customer Interview
Using NGS to Study Rare Undiagnosed Genetic Disease
Whole-exome and transcriptome sequencing prove beneficial in uncovering mutations and pathways associated with rare disease.
Read Article
Customer Interview
Seeking the Source of Bacterial Drug Resistance
A targeted deep sequencing assay identifies multidrug-resistant tuberculosis strains responsible for silent outbreaks.
Read Article
Customer Videos
Take a tour with Professor Michael Bunce to learn about eDNA through...
Professor Bunce explores our deep seas and gives insight into eDNA analysis through metabarcoding.
View VideoProfile Accessible Chromatin across the Genome with ATAC-Seq
Uncover how chromatin packaging and other factors affect gene expression
Learn MoreEpisode 59: Drug Discovery through Gene Regulation
Many more diseases could potentially be treated by controlling the expression of abnormal and normal genes
Listen to PodcastTraining and Webinars
Illumina offers webinars and free online training courses to get the most out of your experiments and products
View WebinarsView CoursesFeatured Tool
Disease to Gene Finder
Data driven approach to rank genes for optimized panel or microarray design
Find Associated GenesPopular Tools
MyIllumina Customer Dashboard
Sign In or Learn MoreLibrary Prep and Array Kit Selector
Launch ToolBaseSpace Sequence Hub
Sign In or Learn MoreCustom Protocol Selector
Build ProtocolDesignStudio Custom Assay Designer
Sign In or Learn More
See More Tools
| Date | Publication | Title |
|---|---|---|
| Feb 7, 2020 | CNBC | Illumina CMO on working with China on coronavirus cure |
| Feb 7, 2020 | The Smithsonian | How Simple Blood Tests Could Revolutionize Cancer Treatment |
| Jan 13, 2020 | CNBC | ILMN CEO at J.P. Morgan Healthcare Conference |